Neuronetics, Inc. (STIM)
1.42
-0.16
(-10.13%)
USD |
NASDAQ |
Feb 13, 16:00
1.46
+0.04
(+2.82%)
After-Hours: 20:00
Neuronetics Total Liabilities (Quarterly) : 114.10M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 50.08M |
| Plus Therapeutics, Inc. | 13.62M |
| Atossa Therapeutics, Inc. | 8.225M |
| Abeona Therapeutics, Inc. | 59.86M |
| Cell Source, Inc. | 19.08M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 145.46M |
| Shareholders Equity (Quarterly) | 27.36M |
| Debt to Equity Ratio | 3.317 |
| Current Ratio | 2.242 |
| Net Debt Paydown Yield | -3.01% |